News & Analysis on Clinical Trial Services & Contract Research And Development
Genomics company, VASTox, has announced encouraging preclinical results in its drug discovery programme, which aims to find the next generation of treatment for Duchenne Muscular Dystrophy (DMD), a disease of which there is no known cure.
Thermo have introduced, what it claims is the next generation of high content screening (HCS), launching a compact system that has a small footprint, which frees up valuable lab floor space. The product additionally offers turnkey simplicity and high...
Covalent Group has signed a new contract worth $2.3 m (€1.9 m) to conduct a global Phase 2 clinical trial of a new antithrombotic agent in the US, Europe, and South America.
ImmuPharma, a drug discovery and development company, are to seek admission to the Alternative Investments Market (AIM), in a move that will give the group the resources necessary to finance initial clinical trials on ImmuPharma's lead drug candidates...
Oxford Immunotec makes available an in vitro diagnostic that measures T-cells specific to Mycobacterium tuberculosis (MTB) antigens diagnosing both latent and active TB infection in immunocompromised humans - a significant problem with some existing...
Pharmaceutical company, Phosphagenics, has announced the commencement of animal studies on its anti-cancer compound, which claims to destroy diseased cells while not affecting normal ones by primarily acting as a signalling molecule and modulator of...
Drug companies are leaning more heavily on contract research organisations (CROs) to save costs in getting new drugs to market. And it is paying off, with added benefits. Companies who rely on CROs are also completing clinical trials faster, according...